CREBBP and diffuse large B-cell lymphoma: Accordingly, KMT2D acetylation levels were significantly lower in native DLBCL cell lines carrying biallelic inactivation of CREBBP (SUDHL16) or lacking the expression of a full-length CREBBP protein (SUDHL10CU) compared to CREBBP wild-type cell lines (SI Appendix, Fig. S7).